1,390
Views
1
CrossRef citations to date
0
Altmetric
Editorial

Art and drug delivery system design: dissonance or a harmony?

, &
Pages 735-739 | Received 08 Feb 2020, Accepted 02 Apr 2020, Published online: 13 Apr 2020

References

  • Yun YH, Lee BK, Park K. Controlled drug delivery: historical perspective for the next generation. J Control Release. 2015;219:2–7.
  • Gelvin EP, McGavack TH, Kenigsberg S. The anorexigenic effect of sustained-release dexedrine preparations. Am J Digestive Dis. 1953;20(10):307.
  • Abu-Thabit NY, Makhlouf ASH. Historical development of drug delivery systems: from conventional macroscale to controlled, targeted, and responsive nanoscale systems. In: Hamdy Makhlouf AS and Abu-Thabit NY, editors. Stimuli responsive polymeric nanocarriers for drug delivery applications. Vol. 1. Amsterdam (Netherlands): Elsevier; 2018. p. 3–41.
  • Rezaie HR, Esnaashary M, Arjmand AA, et al. The history of drug delivery systems. A review of biomaterials and their applications in drug delivery. Singapore: Springer; 2018.
  • Bareford LM, Swaan PW. Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev. 2007;59(8):748–758.
  • Manish G, Vimukta S. Targeted drug delivery system: a review. Res J Chem Sci. 2011;1(2):135–138.
  • Karmali PP, Simberg D. Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems. Expert Opin Drug Deliv. 2011;8(3):343–357.
  • Hashida M, Opanasopit P, Nishikawa M. Factors affecting drug and gene delivery: effects of interaction with blood components. Crit Revi™ Ther Drug Carrier Syst. 2002;19(3):191–233.
  • Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015;33(9):941.
  • Danhier F, Feron O, Préat V. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release. 2010;148(2):135–146.
  • Sezer AD. Application of nanotechnology in drug delivery. Croatia: IntechOpen; 2014.
  • Van der Worp HB, Howells DW, Sena ES, et al., Can animal models of disease reliably inform human studies? PLoS Med. 2010;7(3): e1000245.
  • Prabhakar U, Maeda H, Jain RK, et al. Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res. 2013;73(8):2412–2417.
  • Nichols JW, Bae YH. EPR: evidence and fallacy. J Control Release. 2014;190:451–464.
  • Sun Q, Radosz M, Shen Y. Challenges in design of translational nanocarriers. J Control Release. 2012;164(2):156–169.
  • Fortune JA. Specific and efficient in vivo delivery of DNA and siRNA by polyethylenimine and its derivatives. Cambridge (MA): Massachusetts Institute of Technology; 2010.
  • van Dommelen SM, Vader P, Lakhal S, et al. Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. J Control Release. 2012;161(2):635–644.
  • Vader P, Mol EA, Pasterkamp G, et al. Extracellular vesicles for drug delivery. Adv Drug Deliv Rev. 2016;106:148–156.
  • Alvarez-Erviti L, Seow Y, Yin H, et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29(4):341–345.
  • Abbasi-Malati Z, Roushandeh AM, Kuwahara Y, et al. Mesenchymal stem cells on horizon: a new arsenal of therapeutic agents. Stem Cell Rev Rep. 2018;14(4):484–499.
  • Willmon C, Harrington K, Kottke T, et al. Cell carriers for oncolytic viruses: fed Ex for cancer therapy. Mol Ther. 2009;17(10):1667–1676.
  • Rizwanullah M, Alam M, Mir S, et al. Polymer-lipid hybrid nanoparticles: a next-generation nanocarrier for targeted treatment of solid tumors. Curr Pharm Des. 2020;26(1).
  • Lim WQ, Phua SZF, Xu HV, et al. Recent advances in multifunctional silica-based hybrid nanocarriers for bioimaging and cancer therapy. Nanoscale. 2016;8(25):12510–12519.
  • Li Z, Ye E, Lakshminarayanan R, et al. Recent advances of using hybrid nanocarriers in remotely controlled therapeutic delivery. Small. 2016;12(35):4782–4806.
  • Luo M, Feng Y, Wang T, et al. Micro‐/nanorobots at work in active drug delivery. Adv Funct Mater. 2018;28(25):1706100.
  • Ahmad U, Faiyazuddin MD. Smart nanobots: the future in nanomedicine and biotherapeutics. J NanomedineBiotherapeutic Discov. 2016;6(1):e140.
  • Marshall J. A systems view: the role of art in education. Art Educ. 2016;69(3):12–19.
  • Hui AN, He MW, Ye SS. Arts education and creativity enhancement in young children in Hong Kong. Educ Psychol. 2015;35(3):315–327.
  • Carr MB, Vandiver TA. Effects of instructional art projects on children’s behavioral responses and creativity within an emergency shelter. Art Ther. 2003;20(3):157–162.
  • Djikic M, Oatley K, Zoeterman S, et al. On being moved by art: how reading fiction transforms the self. Creativity Res J. 2009;21(1):24–29.
  • Bolwerk A, Mack-Andrick J, Lang FR, et al. How art changes your brain: differential effects of visual art production and cognitive art evaluation on functional brain connectivity. PloS One. 2014;9(7):e101035.
  • Zaidel DW. Creativity, brain, and art: biological and neurological considerations. Front Hum Neurosci. 2014;8:389.
  • Burton JM, Horowitz R, Abeles H. Learning in and through the arts: the question of transfer. Stud Art Educ. 2000;41(3):228–257.
  • Gromko JE. The effect of music instruction on phonemic awareness in beginning readers. J Res Music Educ. 2005;53(3):199–209.
  • Gromko JE, Poorman AS. The effect of music training on preschoolers’ spatial-temporal task performance. J Res Music Educ. 1998;46(2):173–181.
  • Landy NA. Effects of tactual and kinesthetic instructional resources on Bermudian middle-school students’ vocabulary achievement and attitudes. Queens (NY): St. John’s University; 2005.
  • Mumford MD, Connelly MS, Baughman WA, et al. Creativity and problem solving: cognition, adaptability, and wisdom. Roeper Rev. 1994;16(4)241–246.
  • Ackerman JS. Leonardo da Vinci: art in science. Daedalus. 1998;127(1):207–224.
  • Silverman K. Lightning Man: The Accursed Life Of Samuel F.B. Morse. Da Capo Press; 2004.
  • Llinás RR. The contribution of Santiago Ramon y Cajal to functional neuroscience. Nat Rev Neurosci. 2003;4(1):77–80.
  • Audubon JJ. The life of John James Audubon, the naturalist. Columbus (OH): GP Putnam & son; 1873.
  • Morrison KL, Weiss GA. The origins of chemical biology. Nat Chem Biol. 2006;2(1):3–6.
  • Blombäck B, Alfred L. Copley-The scientist and his contributions to our understanding of haemostasis, thrombosis and atherogenesis. Thromb Res. 1992;66(1):3–10.
  • Shore A. Art therapy, attachment, and the divided brain. Art Ther. 2014;31(2):91–94.
  • Fiore SM, Schooler JW. Right hemisphere contributions to creative problem solving: converging evidence for divergent thinking. L. Erlbaum Associates; 1998.
  • Veltman KH. Leonardo da Vinci: studies of the human body and principles of anatomy. Gepeinigt, begehrt, vergessen Symbolik und Sozialbezug des Körpers im späten Mittelalter und in der frühen Neuzeit. Germany; 1992. p. 287–308.
  • Vinci LD. The Codex Leicester. United Kingdom: Christie, Manson, & Woods; 1980.
  • [ cited 2019 Jan 9]. Available from: https://mediatedmattergroup.com/
  • Kan V, Vargo E, Machover N, et al., editors. Organic primitives: synthesis and design of pH-reactive materials using molecular I/O for sensing, actuation, and interaction. Proceedings of the 2017 CHI conference on human factors in computing systems, Denver, CO; 2017.
  • Bernkop-Schnürch A, Dünnhaupt S. Chitosan-based drug delivery systems. Eur J Pharm Biopharm. 2012;81(3):463–469.
  • Baradaran Eftekhari R, Maghsoudnia N, Samimi S, et al. Application of chitosan in oral drug delivery. In: Jana S, Jana Seditors. Functional chitosan: drug delivery and biomedical applications. Singapore: Springer Singapore; 2019. p. 43–73.
  • Keating S. Beyond 3D printing: the new dimensions of additive fabrication. In: Designing for emerging technologies: UX for genomics, robotics, and the internet of things. Sebastopol (CA): O'Reilly Media. 2014. p. 379.
  • Bawa P, Pillay V, Choonara YE, et al. Stimuli-responsive polymers and their applications in drug delivery. Biomed Mater. 2009;4(2):022001.
  • McCarley RL. Redox-responsive delivery systems. Ann Rev Anal Chem. 2012;5(1):391–411.
  • Deng W, Chen W, Clement S, et al. Controlled gene and drug release from a liposomal delivery platform triggered by X-ray radiation. Nat Commun. 2018 2018/07/13;9(1):2713.
  • Eftekhari RB, Maghsoudnia N, Samimi S, et al. Co-delivery Nanosystems for cancer treatment: A review. Pharm Nanotechnol. 2019;7(2):90–112.
  • Samimi S, Maghsoudnia N, Eftekhari RB, et al. Lipid-based nanoparticles for drug delivery systems. In: Mohapatra SS, Ranjan S, Dasgupta N, et al, editors. Characterization and biology of nanomaterials for drug delivery. Netherlands: Elsevier; 2019. p. 47–76.
  • Baradaran Eftekhari R, Maghsoudnia N, Dorkoosh FA. Chloroquine: A brand-new scenario for an old drug. Exp Opin Drug Del. 2020;17(3):275–277.
  • Choi BH, Kim CG, Lim Y, et al. Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NFκB pathway. Cancer Lett. 2008;259(1):111–118.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.